Goal: To increase the appropriate application of contingent valuation, conjoint analysis, stated choice/preference, discrete-choice experiment and similar methods for assessing patient preferences and values in outcomes research and encourage the use of this information by decision-makers.
ISPOR 12th Annual European Congress in Paris, France
Workshop Session I: Sunday, 25 October 2009, 15:15-16:15
Workshop Description
Workshop Presentation
ISPOR 14th Annual International Meeting in Orlando, Florida
Forum: Monday, May 18th, 2009 11:45AM-12:45PM
Conjoint Analysis Good Research Practices Task Force:
I. A Checklist for Good Research Practices for the Application of Conjoint Analysis in Health Care Research
II. Good Research Practices for the Design of Conjoint Analysis
III. Good Research Practices for Analysis & Interpretation of Conjoint Analysis Data
IV. Good Research Practices for Identifying & Valuing Patient Relevant Outcomes
Current Conjoint Analysis Terms Projects: Online Lexicon & ISPOR CONNECTIONS Articles
Chair: Sheryl Szeinbach BS, MS, PhD, RPh, Professor, College of Pharmacy, Ohio State University, Columbus, OH USA
The Terms team has defined more than 50 conjoint analysis terms ranging from Adaptive conjoint analysis to Willingness to pay. Once complete they will submit their findings for publication.
Chair: Andrew Lloyd DPhil, Director, Oxford Outcomes, Oxford, UK
How are patient preferences similar to and different from patient-reported outcomes? Once complete, the article will be submitted to ISPOR CONNECTIONS.
Activities and Accomplishments 2007 - 2008 Leadership Group:
Terry Flynn PhD, Research Fellow, Department of Social Medicine, University of Bristol, Bristol, UK
Scott Gross PhD, Acting Assoc. Director for Science, Division of Human Development and Disability, Centers for Disease Control, Atlanta, GA
Spencer Harpe PharmD, PhD, MPH, Assistant Professor, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA
A. Brett Hauber PhD Senior Economist & Head, Health Preference Assessment, RTI Health Solutions, RTI International,
Research Triangle Park, NC, USA
Joel Hay PhD, Associate Professor, Clinical Pharmacy and Pharmaceutical Economics And Policy University of Southern California,
Los Angeles, CA, USA
Aaron Hill, Director of Client Services, Sawtooth Software, Inc., Sequim, WA, USA
Maarten J. IJzerman PhD, Professor and Chair, Health Technology & Services Research, University of Twente, Enschede, the Netherlands
F. Reed Johnson PhD, Senior Fellow and Principal Economist, Health Preference Assessment Group, RTI Health Solutions, RTI International, Research Triangle Park, NC, USA
Emily Lancsar MEc, Lecturer in Economics, Newcastle University Business School and Institute of Health and Society, Newcastle University, Newcastle, UK
Andrew Lloyd DPhil, Director, Oxford Outcomes, Oxford, UK
Deborah Marshall PhD, Canada Research Chair, Health Services and Systems Research & Associate Professor, Department of Community Health Sciences Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
Jo Mauskopf PhD, Vice President, Health Economics, RTI International, Research Triangle Park, NC, USA and Editor-in-Chief, Value in Health
Axel Mühlbacher PhD, MBA, HS Neubrandenburg, Neubrandenburg, Germany
Ebere Akobundu Onukwugha PhD, Assistant Professor, Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, USA
Lisa A. Prosser PhD, Research Associate Professor, Child Health Evaluation and Research Unit Division of General Pediatrics, University of Michigan Health System, Ann Arbor, MI, USA
Dean Regier PhD, Health Economist, National Perinatal Epidemiology Unit (NPEU), University of Oxford, Oxford, UK
Sheryl Szeinbach BS, MS, PhD, RPh, Professor, College of Pharmacy, Ohio State University, Columbus, OH, USA |
